231.250 Orionin A-osaketta muunnettu B-osakkeiksi
December 12, 2000 02:30 ET
|
Orion Oyj
Orion-yhtymä Oyj:n yhtiöjärjestyksen 3 §:n nojalla 231.250 A-osaketta on muunnettu 231.250 B-osakkeeksi. Muuntaminen on merkitty kaupparekisteriin 12.12.2000. Muuntamisen jälkeen yhtiön osakkeista on...
231,250 Orion A-shares converted into B-shares
December 12, 2000 02:30 ET
|
Orion Oyj
In accordance with Section 3 of the By-Laws of Orion Corporation, 231,250 A-shares have been converted into 231,250 B-shares. The conversion has been entered into the Trade Register on 12 December...
Nokia introduces the Nokia 505 mobile phone for ETACS networks
December 12, 2000 02:01 ET
|
Nokia Oyj
Nokia has today announced a Nokia 505 analog mobile phone for ETACS networks in Malaysia. The Nokia 505 is a compact and stylish phone equipped with the famous Nokia Navi(TM) key. The Navi(TM)key...
Kilroy Realty Corporation Announces Fourth Quarter Dividend
December 11, 2000 17:33 ET
|
Kilroy Realty Corporation
LOS ANGELES, Dec. 11, 2000 (PRIMEZONE) -- Kilroy Realty Corporation (NYSE:KRC) announced today that its board of directors has declared a regular quarterly cash dividend of $0.45 per common share...
Entire Board of Directors now composed of company-external members only
December 11, 2000 12:00 ET
|
Orion Oyj
At its meeting held today, the Supervisory Board of Orion Corporation decided to change the composition of the Board of Directors to consist of company-external members only. Therefore, Jukka...
Orion-yhtymä Oyj:lle kokonaan ulkopuolisista jäsenistä muodostuva hallitus
December 11, 2000 12:00 ET
|
Orion Oyj
Orion-yhtymä Oyj:n hallintoneuvosto on tänään pitämässään kokouksessa päättänyt Orion-yhtymän hallituksen kokoonpanosta. Hallitukseen valittiin uusina jäseninä Gyllenberg Asset Management Oy:n...
Positive langtidsresultater med Metvix® fotodynamisk behandling av basal celle cancer (hudkreft).
December 11, 2000 11:03 ET
|
Photocure ASA
PhotoCure informerer i denne melding om positive langtidsresultater etter behandling av Basal Celle Cancer(BCC) med Metvix® fotodynamisk terapi (PDT). Pasienter med BCC vurdert som uegnet for...
Northrop Grumman Receives $12.1 Million Contract for TPS-75 Missile Tracking Modification Kits
December 11, 2000 11:00 ET
|
Northrop Grumman Corporation
BALTIMORE, Md., Dec. 11, 2000 (PRIMEZONE) -- Northrop Grumman Corporation's (NYSE:NOC) Electronic Sensors and Systems Sector (ES3) has been awarded a $12.1 million fixed-price contract from the U.S....
Positive Long Term Results with Metvix® PDT in Basal Cell Carcinoma
December 11, 2000 10:59 ET
|
Photocure ASA
PhotoCure is pleased to announce positive long- term recurrence data from its Metvix® photodynamic therapy (PDT) trial on patients with Basal Cell Carcinoma (BCC) lesions that were deemed unsuitable...
Logicon Wins Safeguard Task Order to Perform Vulnerability Assessments for U.S. Army Reserve Command
December 11, 2000 09:00 ET
|
Northrop Grumman Corporation
HERNDON, Va., Dec. 11, 2000 (PRIMEZONE) -- Logicon Inc., a Northrop Grumman Corporation (NYSE:NOC) company, has been selected by the Department of Defense to lead a team that will conduct...
- May 03, 2024 19:15 ET GDRX Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against GoodRx Holdings, Inc.
- May 03, 2024 19:13 ET ADSK Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against Autodesk, Inc.